Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Influenza

Free Subscription 14.04.2020 1 Antiviral Res 14 BMJ 1 J Clin Microbiol 2 J Exp Med 5 J Infect 4 J Infect Dis 3 J Virol 1 JAMA 15 Lancet 9 Lancet Infect Dis 3 Lancet Oncol 2 Lancet Planet Health 2 Lancet Public Health 8 Lancet Respir Med 5 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 1 Pediatrics 5 PLoS One 4 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. SUZUKI S, Shichinohe S, Itoh Y, Nakayama M, et al
   Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza A virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
   Antiviral Res. 2020 Apr 6:104790. doi: 10.1016/j.antiviral.2020.104790.
   PubMed         Abstract available
   
   

   
   BMJ

2. AHMAD A, Mueller C, Tsamakis K
   Covid-19 pandemic: a public and global mental health opportunity for social transformation?
   BMJ. 2020;369:m1383.
   PubMed        
   
   
3. GREENBERG N, Docherty M, Gnanapragasam S, Wessely S, et al
   Managing mental health challenges faced by healthcare workers during covid-19 pandemic.
   BMJ. 2020;368:m1211.
   PubMed        
   
   
4. HERO I
   Prevent loss of life by providing all NHS staff with WHO standard personal protective equipment.
   BMJ. 2020;368:m1275.
   PubMed        
   
   
5. POLLOCK AM, Roderick P, Cheng KK, Pankhania B, et al
   Covid-19: why is the UK government ignoring WHO's advice?
   BMJ. 2020;368:m1284.
   PubMed        
   
   
6. CHUNG RY, Dong D, Li MM
   Socioeconomic gradient in health and the covid-19 outbreak.
   BMJ. 2020;369:m1329.
   PubMed        
   
   
7. MURRAY R
   Money injection for public services.
   BMJ. 2020;369:m1296.
   PubMed        
   
   
8. DONG Y, Wang L, Burgner DP, Miller JE, et al
   Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
   BMJ. 2020;369:m1043.
   PubMed         Abstract available
   
   
9. ARONSON JK, Ferner RE
   Drugs and the renin-angiotensin system in covid-19.
   BMJ. 2020;369:m1313.
   PubMed        
   
   
10. DROPKIN G
    Covid-19: Contact tracing requires ending the hostile environment.
    BMJ. 2020;368:m1320.
    PubMed        
    
    
11. KICKBUSCH I, Leung GM, Bhutta ZA, Matsoso MP, et al
    Covid-19: how a virus is turning the world upside down.
    BMJ. 2020;369:m1336.
    PubMed        
    
    
12. WYNANTS L, Van Calster B, Bonten MMJ, Collins GS, et al
    Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal.
    BMJ. 2020;369:m1328.
    PubMed         Abstract available
    
    
13. CHEN T, Wu D, Chen H, Yan W, et al
    Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
    BMJ. 2020;368:m1091.
    PubMed         Abstract available
    
    
14. HARGREAVES S, Kumar BN, McKee M, Jones L, et al
    Europe's migrant containment policies threaten the response to covid-19.
    BMJ. 2020;368:m1213.
    PubMed        
    
    
15. CALVO RA, Deterding S, Ryan RM
    Health surveillance during covid-19 pandemic.
    BMJ. 2020;369:m1373.
    PubMed        
    
    

    
    J Clin Microbiol

16. YANG G, Hodges EN, Winter J, Zanders N, et al
    Development of an RNA strand-specific hybridization assay to differentiate replicating versus non-replicating influenza A virus.
    J Clin Microbiol. 2020 Apr 3. pii: JCM.00252-20. doi: 10.1128/JCM.00252.
    PubMed         Abstract available
    
    

    
    J Exp Med

17. NATHAN CF, Nussenzweig MC, Pulvirenti T
    We are here for you and ready to hear from you.
    J Exp Med. 2020;217.
    PubMed        
    
    
18. WEISS SR
    Forty years with coronaviruses.
    J Exp Med. 2020;217.
    PubMed         Abstract available
    
    

    
    J Infect

19. LI R, Qiao S, Zhang G
    Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV.
    J Infect. 2020 Feb 21. pii: S0163-4453(20)30090.
    PubMed        
    
    
20. XU YH, Dong JH, An WM, Lv XY, et al
    Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2.
    J Infect. 2020 Feb 25. pii: S0163-4453(20)30100.
    PubMed         Abstract available
    
    
21. YANG W, Cao Q, Qin L, Wang X, et al
    Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China.
    J Infect. 2020 Feb 26. pii: S0163-4453(20)30099.
    PubMed         Abstract available
    
    
22. TIAN S, Hu N, Lou J, Chen K, et al
    Characteristics of COVID-19 infection in Beijing.
    J Infect. 2020 Feb 27. pii: S0163-4453(20)30101.
    PubMed         Abstract available
    
    
23. HAN Q, Lin Q, Jin S, You L, et al
    Recent insights into 2019-nCoV: a brief but comprehensive review.
    J Infect. 2020 Feb 25. pii: S0163-4453(20)30087.
    PubMed         Abstract available
    
    

    
    J Infect Dis

24. MOHN KG, Brokstad KA, Islam S, Oftung F, et al
    Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    J Infect Dis. 2020;221:1528-1537.
    PubMed         Abstract available
    
    
25. RYU S, Ali ST, Cowling BJ, Lau EHY, et al
    Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
    J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
    PubMed         Abstract available
    
    
26. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    PubMed         Abstract available
    
    
27. SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
    A high fat diet increases influenza A virus-associated cardiovascular damage.
    J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

28. OKUYA K, Yoshida R, Manzoor R, Saito S, et al
    A potential role of non-neutralizing IgA antibodies in cross-protective immunity against influenza A viruses of multiple hemagglutinin subtypes.
    J Virol. 2020 Apr 8. pii: JVI.00408-20. doi: 10.1128/JVI.00408.
    PubMed         Abstract available
    
    
29. PEACOCK TP, Swann OC, Salvesen HA, Staller E, et al
    Swine ANP32A supports avian influenza virus polymerase.
    J Virol. 2020 Apr 8. pii: JVI.00132-20. doi: 10.1128/JVI.00132.
    PubMed         Abstract available
    
    
30. SHIBUYA M, Aoshi T, Kuroda E, Yoshioka Y, et al
    Murine cross-reactive non-neutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice.
    J Virol. 2020 Apr 8. pii: JVI.00323-20. doi: 10.1128/JVI.00323.
    PubMed         Abstract available
    
    

    
    JAMA

31. SAKAMOTO H, Ishikane M, Ueda P
    Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan.
    JAMA. 2020 Apr 10. pii: 2764657. doi: 10.1001/jama.2020.6173.
    PubMed        
    
    

    
    Lancet

32. MCCLOSKEY B, Zumla A, Ippolito G, Blumberg L, et al
    Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma.
    Lancet. 2020 Mar 20. pii: S0140-6736(20)30681.
    PubMed        
    
    
33. FISHER D, Wilder-Smith A
    The global community needs to swiftly ramp up the response to contain COVID-19.
    Lancet. 2020 Mar 19. pii: S0140-6736(20)30679.
    PubMed        
    
    
34. JACOBSEN KH
    Will COVID-19 generate global preparedness?
    Lancet. 2020 Mar 18. pii: S0140-6736(20)30559.
    PubMed        
    
    
35. PETHERICK A
    Developing antibody tests for SARS-CoV-2.
    Lancet. 2020;395:1101-1102.
    PubMed        
    
    
36. WEISS P, Murdoch DR
    Clinical course and mortality risk of severe COVID-19.
    Lancet. 2020 Mar 17. pii: S0140-6736(20)30633.
    PubMed        
    
    
37. WANG J, Xu C, Wong YK, He Y, et al
    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30561.
    PubMed        
    
    
38. GHINAI I, McPherson TD, Hunter JC, Kirking HL, et al
    First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.
    Lancet. 2020 Mar 13. pii: S0140-6736(20)30607.
    PubMed         Abstract available
    
    
39. THE LANCET
    COVID-19: learning from experience.
    Lancet. 2020;395:1011.
    PubMed        
    
    
40. RITCHIE AI, Singanayagam A
    Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
    Lancet. 2020;395:1111.
    PubMed        
    
    
41. SAGLIETTO A, D'Ascenzo F, Zoccai GB, De Ferrari GM, et al
    COVID-19 in Europe: the Italian lesson.
    Lancet. 2020;395:1110-1111.
    PubMed        
    
    
42. CHOWELL G, Mizumoto K
    The COVID-19 pandemic in the USA: what might we expect?
    Lancet. 2020;395:1093-1094.
    PubMed        
    
    
43. THE LANCET
    COVID-19 will not leave behind refugees and migrants.
    Lancet. 2020;395:1090.
    PubMed        
    
    
44. BROWN A, Horton R
    A planetary health perspective on COVID-19: a call for papers.
    Lancet. 2020;395:1099.
    PubMed        
    
    
45. THE LANCET
    Redefining vulnerability in the era of COVID-19.
    Lancet. 2020;395:1089.
    PubMed        
    
    
46. ELESSI K, Albarqouni L, Glasziou P, Chalmers I, et al
    Training in critical appraisal skills: Authors' reply.
    Lancet. 2020;395:e60.
    PubMed        
    
    

    
    Lancet Infect Dis

47. CHEN L, Xiong J, Bao L, Shi Y, et al
    Convalescent plasma as a potential therapy for COVID-19.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30141.
    PubMed        
    
    
48. ZHOU C, Gao C, Xie Y, Xu M, et al
    COVID-19 with spontaneous pneumomediastinum.
    Lancet Infect Dis. 2020 Mar 9. pii: S1473-3099(20)30156.
    PubMed        
    
    
49. PAN X, Chen D, Xia Y, Wu X, et al
    Asymptomatic cases in a family cluster with SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30114.
    PubMed        
    
    
50. SHI H, Han X, Jiang N, Cao Y, et al
    Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30086.
    PubMed         Abstract available
    
    
51. DEVI S
    US public health budget cuts in the face of COVID-19.
    Lancet Infect Dis. 2020;20:415.
    PubMed        
    
    
52. THE LANCET INFECTIOUS DISEASES
    COVID-19, a pandemic or not?
    Lancet Infect Dis. 2020 Mar 13. pii: S1473-3099(20)30180.
    PubMed        
    
    
53. VAN CUONG L, Giang HTN, Linh LK, Shah J, et al
    The first Vietnamese case of COVID-19 acquired from China.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30111.
    PubMed        
    
    
54. STEBBING J, Phelan A, Griffin I, Tucker C, et al
    COVID-19: combining antiviral and anti-inflammatory treatments.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30132.
    PubMed        
    
    
55. PAN Y, Zhang D, Yang P, Poon LLM, et al
    Viral load of SARS-CoV-2 in clinical samples.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30113.
    PubMed        
    
    

    
    Lancet Oncol

56. THE LANCET ONCOLOGY
    COVID-19: global consequences for oncology.
    Lancet Oncol. 2020;21:467.
    PubMed        
    
    
57. XIA Y, Jin R, Zhao J, Li W, et al
    Risk of COVID-19 for cancer patients.
    Lancet Oncol. 2020 Mar 3. pii: S1470-2045(20)30150.
    PubMed        
    
    
58. WANG H, Zhang L
    Risk of COVID-19 for patients with cancer.
    Lancet Oncol. 2020 Mar 3. pii: S1470-2045(20)30149.
    PubMed        
    
    

    
    Lancet Planet Health

59. KOCK RA, Karesh WB, Veas F, Velavan TP, et al
    2019-nCoV in context: lessons learned?
    Lancet Planet Health. 2020 Feb 6. pii: S2542-5196(20)30035.
    PubMed        
    
    
60. JI JS
    Origins of MERS-CoV, and lessons for 2019-nCoV.
    Lancet Planet Health. 2020 Jan 30. pii: S2542-5196(20)30032.
    PubMed        
    
    

    
    Lancet Public Health

61. KINNER SA, Young JT, Snow K, Southalan L, et al
    Prisons and custodial settings are part of a comprehensive response to COVID-19.
    Lancet Public Health. 2020 Mar 17. pii: S2468-2667(20)30058.
    PubMed        
    
    
62. TSAI J, Wilson M
    COVID-19: a potential public health problem for homeless populations.
    Lancet Public Health. 2020 Mar 11. pii: S2468-2667(20)30053.
    PubMed        
    
    

    
    Lancet Respir Med

63. LI L, Xv Q, Yan J
    COVID-19: the need for continuous medical education and training.
    Lancet Respir Med. 2020 Mar 16. pii: S2213-2600(20)30125.
    PubMed        
    
    
64. THE LANCET RESPIRATORY MEDICIN
    COVID-19: delay, mitigate, and communicate.
    Lancet Respir Med. 2020 Mar 16. pii: S2213-2600(20)30128.
    PubMed        
    
    
65. HENRY BM
    COVID-19, ECMO, and lymphopenia: a word of caution.
    Lancet Respir Med. 2020 Mar 13. pii: S2213-2600(20)30119.
    PubMed        
    
    
66. CAI H
    Sex difference and smoking predisposition in patients with COVID-19.
    Lancet Respir Med. 2020 Mar 11. pii: S2213-2600(20)30117.
    PubMed        
    
    
67. AYEBARE RR, Flick R, Okware S, Bodo B, et al
    Adoption of COVID-19 triage strategies for low-income settings.
    Lancet Respir Med. 2020 Mar 11. pii: S2213-2600(20)30114.
    PubMed        
    
    
68. FANG L, Karakiulakis G, Roth M
    Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
    Lancet Respir Med. 2020 Mar 11. pii: S2213-2600(20)30116.
    PubMed        
    
    
69. NAMENDYS-SILVA SA
    Respiratory support for patients with COVID-19 infection.
    Lancet Respir Med. 2020 Mar 5. pii: S2213-2600(20)30110.
    PubMed        
    
    
70. CHEUNG JC, Ho LT, Cheng JV, Cham EYK, et al
    Staff safety during emergency airway management for COVID-19 in Hong Kong.
    Lancet Respir Med. 2020 Feb 24. pii: S2213-2600(20)30084.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

71. 
    Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:382-386.
    PubMed         Abstract available
    
    
72. KIMBALL A, Hatfield KM, Arons M, James A, et al
    Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:377-381.
    PubMed         Abstract available
    
    
73. PEDERSEN R, Barton V, Tripp J, Blanton L, et al
    Notes from the Field: Seasonal Human Influenza A(H3N2) and Influenza A(H1N1)pdm09 Reassortant Infection - Idaho, 2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:427-428.
    PubMed        
    
    
74. ZWALD ML, Lin W, Sondermeyer Cooksey GL, Weiss C, et al
    Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:419-421.
    PubMed         Abstract available
    
    
75. 
    Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:422-426.
    PubMed         Abstract available
    
    

    
    N Engl J Med

76. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Lessons from Covid-19 Hotspots.
    N Engl J Med. 2020;382:e35.
    PubMed        
    
    
77. LIU W, Zhang Q, Chen J, Xiang R, et al
    Detection of Covid-19 in Children in Early January 2020 in Wuhan, China.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMc2003717.
    PubMed        
    
    
78. MORENS DM, Daszak P, Taubenberger JK
    Escaping Pandora's Box - Another Novel Coronavirus.
    N Engl J Med. 2020;382:1293-1295.
    PubMed        
    
    

    
    Pediatrics

79. ALCAMO AM, Wolf MS, Alessi LJ, Chong HJ, et al
    Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis.
    Pediatrics. 2019 Dec 11. pii: peds.2019-1632. doi: 10.1542/peds.2019-1632.
    PubMed         Abstract available
    
    

    
    PLoS One

80. PETROPOULOS F, Makridakis S
    Forecasting the novel coronavirus COVID-19.
    PLoS One. 2020;15:e0231236.
    PubMed         Abstract available
    
    
81. JIAO P, Fan W, Cao Y, Zhang H, et al
    Robust induction of interferon and interferon-stimulated gene expression by influenza B/Yamagata lineage virus infection of A549 cells.
    PLoS One. 2020;15:e0231039.
    PubMed         Abstract available
    
    
82. TUCKERMAN J, Crawford NW, Marshall HS
    Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination.
    PLoS One. 2020;15:e0230425.
    PubMed         Abstract available
    
    
83. ANASTASSOPOULOU C, Russo L, Tsakris A, Siettos C, et al
    Data-based analysis, modelling and forecasting of the COVID-19 outbreak.
    PLoS One. 2020;15:e0230405.
    PubMed         Abstract available
    
    
84. PIEDRA FA, Qiu X, Teng MN, Avadhanula V, et al
    Non-gradient and genotype-dependent patterns of RSV gene expression.
    PLoS One. 2020;15:e0227558.
    PubMed         Abstract available
    
    

    
    Vaccine

85. WANG SH, Chen J, Smith D, Cao Z, et al
    A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.
    Vaccine. 2020;38:3537-3544.
    PubMed         Abstract available
    
    
86. SURAGH TA, Hibbs B, Marquez P, McNeil MM, et al
    Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30418.
    PubMed         Abstract available
    
    
87. SUGISHITA Y, Nakayama T, Sugawara T, Ohkusa Y, et al
    Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30378.
    PubMed         Abstract available
    
    
88. NGUYEN VH, Vizzotti C, Uruena A, Giglio N, et al
    Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.
    Vaccine. 2020;38:3682-3689.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: